Our Website Uses Cookies 

We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.

For more information, please contact us or consult our Privacy Notice.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Rujul Desai advises clients on drug pricing, market access, reimbursement, strategic contracting, and regulatory solutions for drugs, biologicals, devices, and diagnostics. He brings deep experience with biopharma, specialty pharmacy, and pharmacy benefit management (PBM) companies.

Mr. Desai has held a number of leadership roles in the biopharma, PBM, and specialty pharmacy industry, including with CVS Caremark, UCB, and most recently as Vice President at Avalere Health. He has led engagements across a wide range of U.S. and global market access and reimbursement issues, including optimizing new product launches, pricing, PBM and payer formulary access, value-based contracting, distribution network design, patient access and hub services, affordability programs, e-prescribing, digital health, and the use of health economic data and modeling.

  • Supported pricing, contracting, distribution and market access strategy for several recent specialty product launches in oncology, immunology, neurology, and rare diseases.
  • Developed value-based contracts, outcomes measures, technology platforms, and clinical services for biopharma clients across several therapeutic areas.
  • Advised on coverage, coding and reimbursement approaches for a blue tooth enabled drug dispensing device and related technologies. Assessing market opportunities across payer types, settings of care, and disease states, including potential of integrated bundled drug and diagnostic test offering.
  • Led strategic review of global Health Technology Assessment (HTA) engagement preparedness and tactical plans for newly launched product.
  • Developed strategic plan for seeking improved payment options for medical foods product.
  • Provided health care, compliance, market access, privacy, and FDA advisory advice to Pear Therapeutics, Inc., a prescription digital therapeutic company based in Boston.
  • Conducted independent analysis for biopharma pricing committee to inform product launch pricing and PBM rebate strategies.
  • Designed specialty pharmacy distribution network contracts, as well as patient hub service programs for several orphan products.
  • Developed pricing, contracting, and payer messaging strategies for biopharma client to address competitor biosimilar market entry.
  • Conducted assessment of digital health and e-prescribing impact to market access contracting and provider messaging for biopharma clients.

Pro Bono

  • Volunteer for citizenship clinics hosted by the Asian Pacific American Legal Resource Center.

Memberships and Affiliations

  • American Health Lawyers Association
  • Cancer Support Community, Policy Advisory Board
  • The South Asian Bar Association of Washington D.C.

Previous Experience

  • Avalere Health, Vice President
  • CVS Caremark, Director, Legal
  • UCB, Associate General Counsel
  • U.S. Army Reserves, Captain in the Medical Services Corps